Global Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

The Global Oral Antiviral Market size is expected to reach $41.2 billion by 2029, rising at a market growth of 2.3% CAGR during the forecast period.

Influenza constitutes a significant share of the market and generated $2,811.5 million revenue in 2022 as children are effective recipients of influenza viruses, and those aged 5 to 9 often have the highest rates of infection and sickness. The worldwide prevalence of influenza and the rising number of drug launches are the main drivers of the expansion of the market. As a result, players are concentrating on research & development with potential candidates to address the substantial unmet demands in the market. Some of the factors impacting the market are growing incidence of viral infection, growing Healthcare expenditures, and limited options of accessible, affordable, and broad-spectrum oral antivirals.

Viral infections are now much more common than they were in the recent past. It depends on a variety of conditions whether new infectious diseases originate, or "old" infectious diseases reemerge. Many diseases are brought on by human behavior and habits; however, some are the consequence of natural processes like the development of pathogens over time. The increasing number & size of investments made within the healthcare industry by governments of different nations is one of the primary drivers of the market's growth. Because of their rapid economic development and rising healthcare expenses, more developing countries are projected to have more access to high-quality healthcare.

However, it takes time to create a targeted, safe, and effective antiviral from the beginning, which is anticipated to restrain market revenue growth. Future viral pandemics highlight the need for broad-spectrum antiviral medications, like direct-acting antivirals, that may be promptly and broadly deployed to stop viral spread while effective vaccinations are being developed.

Indication Outlook

Based on indication, the market is segmented into hepatitis, human immunodeficiency virus (HIV), influenza and others. In 2022, the human immunodeficiency virus (HIV) segment held the highest revenue share in the market. The market is predicted to grow faster than average due to the high incidence of HIV infection, availability of branded medications, high treatment rate, and government attempts to raise the treatment rate.

Drug Class Outlook

On the basis of drug class, the market is fragmented into protease inhibitors, reverse transcriptase inhibitors, and others. The protease inhibitors segment garnered a significant revenue share in the market in 2022. Protease inhibitors are drugs that work by obstructing the protein-cleaving enzymes. Among the most well-known are antiviral medications frequently used to treat HIV/AIDS, hepatitis C, and COVID-19. Protease inhibitors are widely used to treat HIV and hepatitis, driving market expansion in this segment.

Distribution Channel Outlook

By distribution channel, the market is bifurcated into hospital pharmacies, drug store & retail pharmacies, and online providers. The online providers segment recorded a remarkable revenue share in the market in 2022. This is because online pharmacies are becoming more and more well-liked by the general population. They also provide discounts and cost-effective solutions. This segment's revenue growth is also aided by easier access to online services and a quicker increase in Internet users. Due to the cheaper pricing compared to other merchants and physical stores, most people prefer to purchase online.

Oral Antiviral Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 35.2 Billion
Market size forecast in 2029	USD 41.2 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2029
Revenue Growth Rate	CAGR of 2.3% from 2023 to 2029
Number of Pages	215
Number of Table	360
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Indication, Drug Class, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growing Healthcare expenditures Growing incidence of viral infection
Restraints	Limited options of accessible, affordable, and broad-spectrum oral antivirals

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the largest revenue share. The rise in the prevalence of viral illnesses including the human immunodeficiency virus (HIV) and hepatitis C, the presence of major manufacturers of oral antivirals, and improvements in healthcare infrastructure all contribute to the market growth.

Free Valuable Insights: Global Oral Antiviral Market size to reach USD 41.2 Billion by 2029

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol Myers Squibb Company, Gilead Sciences, Inc., Viatris, Inc. (Mylan N.V.), AbbVie, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceutical Industries Ltd., and Amneal Pharmaceuticals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Indication

• Human Immunodeficiency Virus (HIV)
• Hepatitis
• Influenza
• Others

By Drug Class

• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Others

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.
• Viatris, Inc. (Mylan N.V.)
• AbbVie, Inc.
• GlaxoSmithKline PLC (GSK)
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Oral Antiviral Market, by Indication
1.4.2 Global Oral Antiviral Market, by Drug Class
1.4.3 Global Oral Antiviral Market, by Distribution Channel
1.4.4 Global Oral Antiviral Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Oral Antiviral Market by Indication
3.1 Global Human Immunodeficiency Virus (HIV) Market by Region
3.2 Global Hepatitis Market by Region
3.3 Global Influenza Market by Region
3.4 Global Others Market by Region

Chapter 4. Global Oral Antiviral Market by Drug Class
4.1 Global Reverse Transcriptase Inhibitors Market by Region
4.2 Global Protease Inhibitors Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Oral Antiviral Market by Distribution Channel
5.1 Global Drug Store & Retail Pharmacies Market by Region
5.2 Global Hospital Pharmacies Market by Region
5.3 Global Online Providers Market by Region

Chapter 6. Global Oral Antiviral Market by Region
6.1 North America Oral Antiviral Market
6.1.1 North America Oral Antiviral Market by Indication
6.1.1.1 North America Human Immunodeficiency Virus (HIV) Market by Country
6.1.1.2 North America Hepatitis Market by Country
6.1.1.3 North America Influenza Market by Country
6.1.1.4 North America Others Market by Country
6.1.2 North America Oral Antiviral Market by Drug Class
6.1.2.1 North America Reverse Transcriptase Inhibitors Market by Country
6.1.2.2 North America Protease Inhibitors Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America Oral Antiviral Market by Distribution Channel
6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
6.1.3.2 North America Hospital Pharmacies Market by Country
6.1.3.3 North America Online Providers Market by Country
6.1.4 North America Oral Antiviral Market by Country
6.1.4.1 US Oral Antiviral Market
6.1.4.1.1 US Oral Antiviral Market by Indication
6.1.4.1.2 US Oral Antiviral Market by Drug Class
6.1.4.1.3 US Oral Antiviral Market by Distribution Channel
6.1.4.2 Canada Oral Antiviral Market
6.1.4.2.1 Canada Oral Antiviral Market by Indication
6.1.4.2.2 Canada Oral Antiviral Market by Drug Class
6.1.4.2.3 Canada Oral Antiviral Market by Distribution Channel
6.1.4.3 Mexico Oral Antiviral Market
6.1.4.3.1 Mexico Oral Antiviral Market by Indication
6.1.4.3.2 Mexico Oral Antiviral Market by Drug Class
6.1.4.3.3 Mexico Oral Antiviral Market by Distribution Channel
6.1.4.4 Rest of North America Oral Antiviral Market
6.1.4.4.1 Rest of North America Oral Antiviral Market by Indication
6.1.4.4.2 Rest of North America Oral Antiviral Market by Drug Class
6.1.4.4.3 Rest of North America Oral Antiviral Market by Distribution Channel
6.2 Europe Oral Antiviral Market
6.2.1 Europe Oral Antiviral Market by Indication
6.2.1.1 Europe Human Immunodeficiency Virus (HIV) Market by Country
6.2.1.2 Europe Hepatitis Market by Country
6.2.1.3 Europe Influenza Market by Country
6.2.1.4 Europe Others Market by Country
6.2.2 Europe Oral Antiviral Market by Drug Class
6.2.2.1 Europe Reverse Transcriptase Inhibitors Market by Country
6.2.2.2 Europe Protease Inhibitors Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe Oral Antiviral Market by Distribution Channel
6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
6.2.3.2 Europe Hospital Pharmacies Market by Country
6.2.3.3 Europe Online Providers Market by Country
6.2.4 Europe Oral Antiviral Market by Country
6.2.4.1 Germany Oral Antiviral Market
6.2.4.1.1 Germany Oral Antiviral Market by Indication
6.2.4.1.2 Germany Oral Antiviral Market by Drug Class
6.2.4.1.3 Germany Oral Antiviral Market by Distribution Channel
6.2.4.2 UK Oral Antiviral Market
6.2.4.2.1 UK Oral Antiviral Market by Indication
6.2.4.2.2 UK Oral Antiviral Market by Drug Class
6.2.4.2.3 UK Oral Antiviral Market by Distribution Channel
6.2.4.3 France Oral Antiviral Market
6.2.4.3.1 France Oral Antiviral Market by Indication
6.2.4.3.2 France Oral Antiviral Market by Drug Class
6.2.4.3.3 France Oral Antiviral Market by Distribution Channel
6.2.4.4 Russia Oral Antiviral Market
6.2.4.4.1 Russia Oral Antiviral Market by Indication
6.2.4.4.2 Russia Oral Antiviral Market by Drug Class
6.2.4.4.3 Russia Oral Antiviral Market by Distribution Channel
6.2.4.5 Spain Oral Antiviral Market
6.2.4.5.1 Spain Oral Antiviral Market by Indication
6.2.4.5.2 Spain Oral Antiviral Market by Drug Class
6.2.4.5.3 Spain Oral Antiviral Market by Distribution Channel
6.2.4.6 Italy Oral Antiviral Market
6.2.4.6.1 Italy Oral Antiviral Market by Indication
6.2.4.6.2 Italy Oral Antiviral Market by Drug Class
6.2.4.6.3 Italy Oral Antiviral Market by Distribution Channel
6.2.4.7 Rest of Europe Oral Antiviral Market
6.2.4.7.1 Rest of Europe Oral Antiviral Market by Indication
6.2.4.7.2 Rest of Europe Oral Antiviral Market by Drug Class
6.2.4.7.3 Rest of Europe Oral Antiviral Market by Distribution Channel
6.3 Asia Pacific Oral Antiviral Market
6.3.1 Asia Pacific Oral Antiviral Market by Indication
6.3.1.1 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country
6.3.1.2 Asia Pacific Hepatitis Market by Country
6.3.1.3 Asia Pacific Influenza Market by Country
6.3.1.4 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Oral Antiviral Market by Drug Class
6.3.2.1 Asia Pacific Reverse Transcriptase Inhibitors Market by Country
6.3.2.2 Asia Pacific Protease Inhibitors Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Oral Antiviral Market by Distribution Channel
6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
6.3.3.3 Asia Pacific Online Providers Market by Country
6.3.4 Asia Pacific Oral Antiviral Market by Country
6.3.4.1 China Oral Antiviral Market
6.3.4.1.1 China Oral Antiviral Market by Indication
6.3.4.1.2 China Oral Antiviral Market by Drug Class
6.3.4.1.3 China Oral Antiviral Market by Distribution Channel
6.3.4.2 Japan Oral Antiviral Market
6.3.4.2.1 Japan Oral Antiviral Market by Indication
6.3.4.2.2 Japan Oral Antiviral Market by Drug Class
6.3.4.2.3 Japan Oral Antiviral Market by Distribution Channel
6.3.4.3 India Oral Antiviral Market
6.3.4.3.1 India Oral Antiviral Market by Indication
6.3.4.3.2 India Oral Antiviral Market by Drug Class
6.3.4.3.3 India Oral Antiviral Market by Distribution Channel
6.3.4.4 South Korea Oral Antiviral Market
6.3.4.4.1 South Korea Oral Antiviral Market by Indication
6.3.4.4.2 South Korea Oral Antiviral Market by Drug Class
6.3.4.4.3 South Korea Oral Antiviral Market by Distribution Channel
6.3.4.5 Singapore Oral Antiviral Market
6.3.4.5.1 Singapore Oral Antiviral Market by Indication
6.3.4.5.2 Singapore Oral Antiviral Market by Drug Class
6.3.4.5.3 Singapore Oral Antiviral Market by Distribution Channel
6.3.4.6 Malaysia Oral Antiviral Market
6.3.4.6.1 Malaysia Oral Antiviral Market by Indication
6.3.4.6.2 Malaysia Oral Antiviral Market by Drug Class
6.3.4.6.3 Malaysia Oral Antiviral Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Oral Antiviral Market
6.3.4.7.1 Rest of Asia Pacific Oral Antiviral Market by Indication
6.3.4.7.2 Rest of Asia Pacific Oral Antiviral Market by Drug Class
6.3.4.7.3 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel
6.4 LAMEA Oral Antiviral Market
6.4.1 LAMEA Oral Antiviral Market by Indication
6.4.1.1 LAMEA Human Immunodeficiency Virus (HIV) Market by Country
6.4.1.2 LAMEA Hepatitis Market by Country
6.4.1.3 LAMEA Influenza Market by Country
6.4.1.4 LAMEA Others Market by Country
6.4.2 LAMEA Oral Antiviral Market by Drug Class
6.4.2.1 LAMEA Reverse Transcriptase Inhibitors Market by Country
6.4.2.2 LAMEA Protease Inhibitors Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA Oral Antiviral Market by Distribution Channel
6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
6.4.3.2 LAMEA Hospital Pharmacies Market by Country
6.4.3.3 LAMEA Online Providers Market by Country
6.4.4 LAMEA Oral Antiviral Market by Country
6.4.4.1 Brazil Oral Antiviral Market
6.4.4.1.1 Brazil Oral Antiviral Market by Indication
6.4.4.1.2 Brazil Oral Antiviral Market by Drug Class
6.4.4.1.3 Brazil Oral Antiviral Market by Distribution Channel
6.4.4.2 Argentina Oral Antiviral Market
6.4.4.2.1 Argentina Oral Antiviral Market by Indication
6.4.4.2.2 Argentina Oral Antiviral Market by Drug Class
6.4.4.2.3 Argentina Oral Antiviral Market by Distribution Channel
6.4.4.3 UAE Oral Antiviral Market
6.4.4.3.1 UAE Oral Antiviral Market by Indication
6.4.4.3.2 UAE Oral Antiviral Market by Drug Class
6.4.4.3.3 UAE Oral Antiviral Market by Distribution Channel
6.4.4.4 Saudi Arabia Oral Antiviral Market
6.4.4.4.1 Saudi Arabia Oral Antiviral Market by Indication
6.4.4.4.2 Saudi Arabia Oral Antiviral Market by Drug Class
6.4.4.4.3 Saudi Arabia Oral Antiviral Market by Distribution Channel
6.4.4.5 South Africa Oral Antiviral Market
6.4.4.5.1 South Africa Oral Antiviral Market by Indication
6.4.4.5.2 South Africa Oral Antiviral Market by Drug Class
6.4.4.5.3 South Africa Oral Antiviral Market by Distribution Channel
6.4.4.6 Nigeria Oral Antiviral Market
6.4.4.6.1 Nigeria Oral Antiviral Market by Indication
6.4.4.6.2 Nigeria Oral Antiviral Market by Drug Class
6.4.4.6.3 Nigeria Oral Antiviral Market by Distribution Channel
6.4.4.7 Rest of LAMEA Oral Antiviral Market
6.4.4.7.1 Rest of LAMEA Oral Antiviral Market by Indication
6.4.4.7.2 Rest of LAMEA Oral Antiviral Market by Drug Class
6.4.4.7.3 Rest of LAMEA Oral Antiviral Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Bristol Myers Squibb Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Gilead Sciences, Inc.
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Viatris, Inc. (Mylan N.V.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expense
7.7 AbbVie, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 GlaxoSmithKline PLC (GSK)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses

TABLE 1 Global Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 2 Global Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 3 Global Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 4 Global Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 5 Global Human Immunodeficiency Virus (HIV) Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Human Immunodeficiency Virus (HIV) Market by Region, 2023 - 2029, USD Million
TABLE 7 Global Hepatitis Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Hepatitis Market by Region, 2023 - 2029, USD Million
TABLE 9 Global Influenza Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Influenza Market by Region, 2023 - 2029, USD Million
TABLE 11 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 14 Global Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 15 Global Reverse Transcriptase Inhibitors Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Reverse Transcriptase Inhibitors Market by Region, 2023 - 2029, USD Million
TABLE 17 Global Protease Inhibitors Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Protease Inhibitors Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Global Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Global Drug Store & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Drug Store & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 25 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Online Providers Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Online Providers Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Oral Antiviral Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Oral Antiviral Market by Region, 2023 - 2029, USD Million
TABLE 31 North America Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 32 North America Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 33 North America Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 34 North America Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 35 North America Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 37 North America Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Influenza Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Influenza Market by Country, 2023 - 2029, USD Million
TABLE 41 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 North America Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 45 North America Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 47 North America Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 51 North America Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 North America Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 61 US Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 62 US Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 63 US Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 64 US Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 65 US Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 66 US Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 67 US Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 US Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 69 Canada Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 70 Canada Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 71 Canada Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 72 Canada Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 73 Canada Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 74 Canada Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 75 Canada Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Canada Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 77 Mexico Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 78 Mexico Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 79 Mexico Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 80 Mexico Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 81 Mexico Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 82 Mexico Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 83 Mexico Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Mexico Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 85 Rest of North America Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 86 Rest of North America Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 87 Rest of North America Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 88 Rest of North America Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 89 Rest of North America Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 90 Rest of North America Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 91 Rest of North America Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 92 Rest of North America Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 93 Europe Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 94 Europe Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 95 Europe Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 96 Europe Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 97 Europe Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 98 Europe Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 99 Europe Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 100 Europe Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 101 Europe Influenza Market by Country, 2019 - 2022, USD Million
TABLE 102 Europe Influenza Market by Country, 2023 - 2029, USD Million
TABLE 103 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 104 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 105 Europe Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 106 Europe Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 107 Europe Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 110 Europe Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 111 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 114 Europe Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 115 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 117 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 121 Europe Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 123 Germany Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 124 Germany Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 125 Germany Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 126 Germany Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 127 Germany Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 128 Germany Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 129 Germany Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 130 Germany Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 131 UK Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 132 UK Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 133 UK Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 134 UK Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 135 UK Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 136 UK Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 137 UK Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 138 UK Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 139 France Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 140 France Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 141 France Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 142 France Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 143 France Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 144 France Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 145 France Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 146 France Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 147 Russia Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 148 Russia Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 149 Russia Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 150 Russia Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 151 Russia Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 152 Russia Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 153 Russia Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 154 Russia Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 155 Spain Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 156 Spain Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 157 Spain Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 158 Spain Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 159 Spain Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 160 Spain Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 161 Spain Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 162 Spain Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 163 Italy Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 164 Italy Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 165 Italy Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 166 Italy Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 167 Italy Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 168 Italy Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 169 Italy Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 170 Italy Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 171 Rest of Europe Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 172 Rest of Europe Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 173 Rest of Europe Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 174 Rest of Europe Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 175 Rest of Europe Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 176 Rest of Europe Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 177 Rest of Europe Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 178 Rest of Europe Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 179 Asia Pacific Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 180 Asia Pacific Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 181 Asia Pacific Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 182 Asia Pacific Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 183 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 184 Asia Pacific Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 185 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 186 Asia Pacific Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 187 Asia Pacific Influenza Market by Country, 2019 - 2022, USD Million
TABLE 188 Asia Pacific Influenza Market by Country, 2023 - 2029, USD Million
TABLE 189 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 191 Asia Pacific Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 193 Asia Pacific Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 194 Asia Pacific Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 195 Asia Pacific Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 196 Asia Pacific Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 199 Asia Pacific Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 200 Asia Pacific Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 205 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 207 Asia Pacific Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 209 China Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 210 China Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 211 China Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 212 China Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 213 China Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 214 China Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 215 China Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 216 China Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 217 Japan Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 218 Japan Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 219 Japan Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 220 Japan Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 221 Japan Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 222 Japan Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 223 Japan Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 224 Japan Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 225 India Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 226 India Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 227 India Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 228 India Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 229 India Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 230 India Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 231 India Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 232 India Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 233 South Korea Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 234 South Korea Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 235 South Korea Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 236 South Korea Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 237 South Korea Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 238 South Korea Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 239 South Korea Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 South Korea Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 241 Singapore Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 242 Singapore Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 243 Singapore Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 244 Singapore Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 245 Singapore Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 246 Singapore Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 247 Singapore Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 248 Singapore Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 249 Malaysia Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 250 Malaysia Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 251 Malaysia Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 252 Malaysia Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 253 Malaysia Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 254 Malaysia Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 255 Malaysia Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 256 Malaysia Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 257 Rest of Asia Pacific Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 258 Rest of Asia Pacific Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 259 Rest of Asia Pacific Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 260 Rest of Asia Pacific Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 261 Rest of Asia Pacific Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 262 Rest of Asia Pacific Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 263 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 264 Rest of Asia Pacific Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 265 LAMEA Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 266 LAMEA Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 267 LAMEA Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 268 LAMEA Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 269 LAMEA Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 270 LAMEA Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 271 LAMEA Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 272 LAMEA Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 273 LAMEA Influenza Market by Country, 2019 - 2022, USD Million
TABLE 274 LAMEA Influenza Market by Country, 2023 - 2029, USD Million
TABLE 275 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 276 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 277 LAMEA Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 278 LAMEA Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 279 LAMEA Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 280 LAMEA Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 281 LAMEA Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 282 LAMEA Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 283 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 284 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 285 LAMEA Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 286 LAMEA Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 287 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 288 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 289 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 290 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 291 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 292 LAMEA Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 293 LAMEA Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 294 LAMEA Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 295 Brazil Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 296 Brazil Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 297 Brazil Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 298 Brazil Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 299 Brazil Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 300 Brazil Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 301 Brazil Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 302 Brazil Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 303 Argentina Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 304 Argentina Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 305 Argentina Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 306 Argentina Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 307 Argentina Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 308 Argentina Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 309 Argentina Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 310 Argentina Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 311 UAE Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 312 UAE Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 313 UAE Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 314 UAE Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 315 UAE Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 316 UAE Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 317 UAE Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 318 UAE Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 319 Saudi Arabia Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 320 Saudi Arabia Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 321 Saudi Arabia Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 322 Saudi Arabia Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 323 Saudi Arabia Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 324 Saudi Arabia Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 325 Saudi Arabia Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 326 Saudi Arabia Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 327 South Africa Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 328 South Africa Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 329 South Africa Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 330 South Africa Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 331 South Africa Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 332 South Africa Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 333 South Africa Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 334 South Africa Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 335 Nigeria Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 336 Nigeria Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 337 Nigeria Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 338 Nigeria Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 339 Nigeria Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 340 Nigeria Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 341 Nigeria Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 342 Nigeria Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 343 Rest of LAMEA Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 344 Rest of LAMEA Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 345 Rest of LAMEA Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 346 Rest of LAMEA Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 347 Rest of LAMEA Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 348 Rest of LAMEA Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 349 Rest of LAMEA Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 350 Rest of LAMEA Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 351 Key information –Johnson & Johnson
TABLE 352 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 353 KEY INFORMATION - Merck & Co., Inc.
TABLE 354 Key Information – Bristol Myers Squibb Company
TABLE 355 Key Information – Gilead Sciences, Inc.
TABLE 356 key information – Viatris, Inc.
TABLE 357 Key information – AbbVie, Inc.
TABLE 358 Key Information – GlaxoSmithKline PLC
TABLE 359 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 360 Key Information – Amneal Pharmaceuticals, INc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Oral Antiviral Market Share by Indication, 2022
FIG 3 Global Oral Antiviral Market Share by Indication, 2029
FIG 4 Global Oral Antiviral Market by Indication, 2019 - 2029, USD Million
FIG 5 Global Oral Antiviral Market Share by Drug Class, 2022
FIG 6 Global Oral Antiviral Market Share by Drug Class, 2029
FIG 7 Global Oral Antiviral Market by Drug Class, 2019 - 2029, USD Million
FIG 8 Global Oral Antiviral Market Share by Distribution Channel, 2022
FIG 9 Global Oral Antiviral Market Share by Distribution Channel, 2029
FIG 10 Global Oral Antiviral Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Global Oral Antiviral Market Share by Region, 2022
FIG 12 Global Oral Antiviral Market Share by Region, 2029
FIG 13 Global Oral Antiviral Market by Region, 2019 - 2029, USD Million
FIG 14 SWOT analysis: Johnson & Johnson